About Miltenyi Biotec
miltenyibiotec.comEmpowering discovery. Advancing therapy. For more than 30 years, Miltenyi Biotec has played an important role in the design, development, manufacture, and integration of products that empower the advancement of biomedical research and enable cell and gene therapy.
SaaS Adoption
SaaS Adoption indicates the level of adoption by this company of software as a service services.
Cloud Adoption
Cloud Adoption indicates the level of adoption by this company of cloud services.
IT Footprint
IT Footprint gives a relative indication of how much IT services this company consumes.
IT Spend
IT Spend shows roughly how much this client spends on IT per year in USD.
Enlyft tracks the use of over 15,000 technologies and has proprietary data on over 18 million companies worldwide.
Know the products your prospects use
Vendor Usage
Miltenyi Biotec uses 5 different technologies from 104 different vendors. They have above average use of several technologies including Microsoft Office 365, SAP R/3 and AdWords.
Product Categories
Miltenyi Biotec uses products from 75 different product categories. They are particularly heavy users of products in Software Frameworks, Enterprise Resource Planning (ERP), and Database Management System.
Recently Detected Technologies
Enlyft tracks the use of over 15,000 technologies and has proprietary data on over 18 million companies worldwide.
| Technology | Category | Vendor | Usage |
|---|---|---|---|
| SAP R/3 | Enterprise Resource Planning (ERP) | SAP |  |
| SAP ERP | Enterprise Resource Planning (ERP) | SAP | |
| SAP S/4HANA | Enterprise Resource Planning (ERP) | SAP |  |
| Microsoft PowerPoint | Office Productivity | Microsoft Corporation | |
| Microsoft Azure AI | Artificial Intelligence | Microsoft Corporation |  |
Are you interested in knowing other companies with similar tech stacks?
What other companies use SAP R/3?
Who are the biggest users of Enterprise Resource Planning (ERP)?
What countries, industries, and company sizes are most likely to use SAP S/4HANA?
